Tag: U.K.
-
Digital Chemistry Start-Up Gains $43M in Early Funds
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round.
-
Companies Partner on Fast Production of Biologics in Plants
The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities.
-
A.I. Analytics Detect Heart Failure in Single Ultrasound View
A system using deep learning algorithms to analyze ultrasound video images is shown to detect a difficult-to diagnose type of heart failure with clips from one view of the heart.
-
Darpa Seeking On-Demand, Distributed Production of Proteins
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.
-
Synthetic Bio Company Manufactures Research Cells
A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality.
-
Companies Partner on A.I., Fusion Energy for Space Flight
A developer of fusion energy for space travel and software company for space flight systems are writing machine learning algorithms to design a hyper-fast rocket engine.
-
Primate Genome A.I. Model IDs Human Disease Variants
A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans.
-
Trial Underway Testing Psychedelic Drug for Depression
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression.
-
Venture Capital Group to Boost Climate Actions
A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals.